Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

Recent & Breaking News (OTCPK:EMMBF)

Emblem Corp. announces new board appointments

GlobeNewswire November 7, 2018

Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma

GlobeNewswire October 24, 2018

VIDEO + B-ROLL: Emblem Corp. CEO Nick Dean welcomes Canada-wide adult-use cannabis legalization

Canada NewsWire October 17, 2018

Emblem Establishes Temporary "Patient Access Investment Fund" to Partially Cover Medical Cannabis Excise Tax

Canada NewsWire October 16, 2018

Emblem Establishes Temporary “Patient Access Investment Fund” to Partially Cover Medical Cannabis Excise Tax

GlobeNewswire October 15, 2018

New Cannabis Ingestion Methods are Arising as the Global Legal Cannabis Market Grows

PR Newswire October 15, 2018

A Letter from Emblem’s President & CEO

GlobeNewswire October 12, 2018

Emblem to supply British Columbia and Saskatchewan markets with high quality cannabis

GlobeNewswire October 12, 2018

Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President

GlobeNewswire October 11, 2018

Rising Number of Approvals for Global Medical Cannabis Products are set to Grow the Market

PR Newswire October 5, 2018

Cannabis Companies are Hot, but This Arbitrage Deal is Even Hotter

PR Newswire October 3, 2018

Global Consumer Spending on Cannabis to Rise as Equity Financing of Startups Grows

PR Newswire September 28, 2018

Emblem Corp. Announces Grant of Stock Options

GlobeNewswire September 25, 2018

Recreational and Medical Cannabis Markets are Spreading Globally

PR Newswire September 25, 2018

Emblem partners with DriveABLE to support research that evaluates impairment risk

GlobeNewswire September 24, 2018

Analyst Projects the Legal Canadian Cannabis Market to Reach CAD 9.2 Billion by 2025

PR Newswire September 20, 2018

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

Newsfile September 18, 2018

Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

GlobeNewswire September 18, 2018

Increasing Demand for Medical Cannabis is set to Grow Globally

PR Newswire September 18, 2018

Emblem and Natura Naturals announce termination of letter of intent

GlobeNewswire September 14, 2018